An official medical spokesperson described the situation of the former Italian Prime Minister Silvio Berlusconi, who has remained under hospital care since early April, as stable and positive. The statement highlights that he is receiving treatment for leukemia within a hospital setting, and that his overall condition permits ongoing inpatient management rather than a transfer to intensive care. The message from the physicians emphasizes continuity of care focused on the hematologic disease, while the patient remains in a standard ward rather than an intensive care unit.
The attending physician, Alberto Zangrillo, conveyed that Berlusconi’s clinical presentation is reassuring. This assessment supports the view that the patient can continue with the established hospitalization plan, which includes standard protocols for leukemia management. The emphasis is on stability that allows for regular monitoring, ongoing laboratory work, and the administration of therapies appropriate to his hematological condition. In such cases, the care team coordinates multidisciplinary input to address any fluctuations in symptoms and to adapt treatment as needed while avoiding unnecessary escalation in the level of care.
According to reputable news sources, Berlusconi is receiving medical attention at a renowned Milan hospital. He is currently not in intensive care and remains under the care of the hospital’s hematology and oncology services. The facility is described as providing comprehensive support for complex blood-related diseases, with a focus on maintaining a steady clinical course through targeted treatment, transfusion management if required, and careful observation for potential complications that can arise with leukemia. The reporting notes that the patient’s stay is part of a broader, planned treatment framework designed to manage the condition while supporting overall health and well-being during the hospital phase.
Earlier communications indicated that Berlusconi experienced respiratory distress associated with his hematologic condition, which necessitated hospitalization. The medical team has since monitored his respiratory status and other vital functions, and the current update underscores that these factors are being managed within the standard care pathway. While the patient is not classified as critically ill at this time, ongoing observation remains essential to detect any changes promptly. The hospital team continues to prioritize a careful balance between effective leukemia treatment and the patient’s comfort, aiming to preserve autonomy and quality of life during the recovery period.